That is very important, because the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective. Simply put, we have to understand how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (jeff brown 2021 stock picks). And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was a breakthrough almost no one saw. But it's going to have extensive implications for curing disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be lots of investment opportunities in this space, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech genome sequencing). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back maybe considerably prior to going greater - black sea. I have actually been covering bitcoin for a long period of time now. One of the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were primarily educating readers. But that's not the big concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown 2021 stock picks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are many fantastic personal companies on the edge of hitting the general public markets And I've been working on a brand-new way for you to invest even prior to these companies go public.
This opportunity has actually been building over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to find out all the information. Go right here to book your spot totally free.
Emma Walsh here, managing editor of the Diary. Regular Journal readers understand that tech isn't our usual beat (jeff brown 2021 predictions). And when it comes to tech investing, we leave it to the professionals. Luckily, we have a number of such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing specialists we understand (jeff brown biotech stocks). In fact, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big image and anticipate what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and much more. These patterns are experiencing rapid development and developing incredible opportunities for investors. I desire to ensure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown stock predictions. However regardless of what numerous readers may think, this is a trend that's simply getting started. Despite the fact that the COVID-19 pandemic interrupted supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still sold.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (what is the legacy report predicting). Losing two months of production and sales really impacts the number of 5G gadgets are sold in the fiscal year. When you consider all of that, selling 250 million systems is amazing. More notably, the delays triggered by the pandemic created a heap of suppressed need. And that demand is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - united arab emirates. Which's not my only 5G forecast When I've talked about 5G in the past, I have actually explained its 3 various stages.
In Phase 2, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Phase Three, 5G services start to be provided (white house). That's when we begin to see applications working on 5G networks. Think about things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase Three by this summer. This begins something of a virtuous cycle: Many people do not actually appreciate the technology. But they will care if there are interesting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open a suite of amazing applications: self-driving automobiles, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment opportunities moving forward will be massive. Stepping far from 5G, the next crucial technology I predict in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it is among the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not operate properly. CRISPR uses a similar concept however with our hereditary code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For many years, CRISPR was mainly a niche technology that wasn't well comprehended. And throughout that time, there were really only three companies operating in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this innovation just works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering incredible returns. This whole market is efficiently a greenfield opportunity.
There's space for numerous business to exist in this area. jeff brown biotech stocks. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or 3 more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software application can accurately anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is necessary due to the fact that the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental process. However now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but numerous drug treatments produced utilizing this innovation. This was one of those advancements that nearly nobody observed. However it's going to have extensive implications for treating disease. And, naturally, there will be a lot of investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it drew back possibly significantly before going higher. I've been covering bitcoin for a very long time now. One of the very first research reports I ever released was on bitcoin - jeff brown biotech genome sequencing. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my recommendation. However at the time of that initial suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
But no one is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. future report. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the details depends on date since February 2021, however we might not independently verify this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like ability to choose winning technology stocks. He spent more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an excellent viewpoint on the market. He's constantly on the hunt for new opportunities, and he shares much of his finest picks in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding track record as a stock-picker, and he successfully forecasted a few of the most significant financial events of the previous twenty years. Although he doesn't appear to release his choices to the public, the service's success is a direct indicator of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal each time, however Jeff Brown's precise predictions have made him legions of dedicated followers. That says a lot about his capability. The Near Future Report is released by Brownstone Research study, a prominent monetary research publisher. Brownstone Research offers a number of research services with a variety of expertises - biotech stocks jeff brown.
The business is also associated with Bonner & Partners, another well-respected research study publisher - social media. On its site, Brownstone says its objective is to supply retail financiers with professional-grade research study: "For too long, the finest investment research has actually not been offered to specific financiers. It has been typically scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. biotech stock. The objective of Brownstone Research is to make that kind of exclusive research offered to any investors aiming to get an edge in the markets. The goal is basic to provide distinct and successful investment research study discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also works as the company's Chief Financial investment Analyst.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After decades of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you know even a little bit about the market, you understand that he has a reputation as a King Midas of sorts. jeff brown 2021 stock predictions. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In reality, Brown thinks S.A.V. democratic republic. could be "the biggest trend of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying two cutting-edge innovations: expert system and electrical cars and trucks. Musk hopes the combination will assist him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing short of the automotive industry's Holy Grail. As you know, electric cars and self-driving car stocks have been big this year, but the Wall Street machine has been huge on buzz without much tangible outcome. Regardless of an extreme boost in competitors over the previous few years, Brown still believes Musk has the very best opportunity of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transportation. Essentially, this technology would permit you to lease your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You just get out of the car and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you understand, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a large portion of the earnings. It sounds ridiculous, however it could be closed than you think.